A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes
Public ClinicalTrials.gov record NCT00002355. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Comparison of Immediate Versus Delayed Treatment With Intravitreal Injections of ISIS 2922 in Patients With Peripheral Cytomegalovirus (CMV) Retinitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine a clinically safe and effective dose of intravitreally injected ISIS 2922 and to compare the safety and efficacy of immediate versus delayed treatment in AIDS patients with previously untreated, peripheral cytomegalovirus ( CMV ) retinitis.
Study identification
- NCT ID
- NCT00002355
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina - Vitreous Associates Med Group | Los Angeles | California | 90017 | — |
| Community Eye Med Group | Pasadena | California | 911052536 | — |
| Santa Clara Valley Med Ctr | San Jose | California | 95128 | — |
| Univ of Colorado Health Sciences Ctr | Denver | Colorado | 80262 | — |
| Dr Julio Perez | Fort Lauderdale | Florida | 33060 | — |
| Georgia Retina | Atlanta | Georgia | 30327 | — |
| Univ of Illinois | Chicago | Illinois | 60612 | — |
| Indiana Univ Med Ctr | Indianapolis | Indiana | 46202 | — |
| Vitreo - Retinal Consultants | New York | New York | 10028 | — |
| Charlotte Eye Ear Nose & Throat Association | Charlotte | North Carolina | 28204 | — |
| Univ of Texas Southwestern Med Ctr of Dallas | Dallas | Texas | 752359057 | — |
| Virginia Eye Consultants | Norfolk | Virginia | 23507 | — |
| Novum Inc | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002355, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00002355 live on ClinicalTrials.gov.